2.10
+0.07(+3.45%)
Currency In USD
| Previous Close | 2.03 |
| Open | 2.02 |
| Day High | 2.1 |
| Day Low | 1.97 |
| 52-Week High | 42.93 |
| 52-Week Low | 1.7 |
| Volume | 231,877 |
| Average Volume | 209,625 |
| Market Cap | 9.37M |
| PE | -0.21 |
| EPS | -10.19 |
| Moving Average 50 Days | 2.67 |
| Moving Average 200 Days | 7.71 |
| Change | 0.07 |
If you invested $1000 in SeaStar Medical Holding Corporation (ICU) since IPO date, it would be worth $8.57 as of December 26, 2024 at a share price of $2.1. Whereas If you bought $1000 worth of SeaStar Medical Holding Corporation (ICU) shares 2 years ago, it would be worth $20.24 as of December 26, 2024 at a share price of $2.1.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial
GlobeNewswire Inc.
Dec 23, 2024 12:00 PM GMT
DENVER, Dec. 23, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that
SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications
GlobeNewswire Inc.
Dec 11, 2024 11:30 AM GMT
U.S. total addressable market for five initial indications is $25 to $33 billion REMINDER: Business Update Conference Call begins at 4:30 p.m. Eastern time today DENVER , Dec. 11, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq
SeaStar Medical to Hold Business Update Conference Call on December 11, 2024
GlobeNewswire Inc.
Dec 04, 2024 1:30 PM GMT
DENVER, Dec. 04, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that